Kuvan (Sapropterin Dihydrochloride) for Improving Gastric Accommodation in Women With Diabetic Gastroparesis (KIGA-DG).
Phase of Trial: Phase II
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Sapropterin (Primary)
- Indications Diabetic gastroparesis
- Focus Therapeutic Use
- Acronyms KIGA-DG
- 09 Feb 2017 Status changed from recruiting to completed.
- 09 Jun 2010 New trial record